Skip to content
  • Log into the Koneksa App
Koneksa
  • Solutions
    • Leading Digital Biomarkers
    • CROs & DCT Partners
  • Therapeutic Focus
    • Neuroscience
    • Parkinson’s Disease
    • Oncology
    • Respiratory
    • Rare Diseases
    • Other Therapeutic Areas
  • Scientific Evidence
    • Clinical Pipeline
    • Publications
  • Resources
    • Resource Library
    • Our Blog
    • Digital Biomarkers FAQ
  • About Us
    • Background & Leadership
    • Our Partnerships
    • News
    • Events
    • Our Culture
  • Contact Us
  • Solutions
    • Leading Digital Biomarkers
    • CROs & DCT Partners
  • Therapeutic Focus
    • Neuroscience
    • Parkinson’s Disease
    • Oncology
    • Respiratory
    • Rare Diseases
    • Other Therapeutic Areas
  • Scientific Evidence
    • Clinical Pipeline
    • Publications
  • Resources
    • Resource Library
    • Our Blog
    • Digital Biomarkers FAQ
  • About Us
    • Background & Leadership
    • Our Partnerships
    • News
    • Events
    • Our Culture
  • Contact Us
  • Log into the Koneksa App
2022

2022

News

Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research

October 25, 2022

News

Koneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease

August 8, 2022

News

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

June 16, 2022

News

Aural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics

June 14, 2022

News

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

February 7, 2022

For the Measures That Matter for Your Trial, Partner With Koneksa

Contact Us
Koneksa
LOG INTO THE KONEKSA APP

© 2023 Koneksa. All Rights Reserved.

  • Privacy Policy
  • Contact Us
LinkedIn Twitter YouTube